{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:24:41Z","timestamp":1792196681260,"version":"4.4.0"},"reference-count":88,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Mediastinal germ cell tumors (MGCTs) share histologic, molecular and biomarkers features with testicular GCTs; however, nonseminomatous MGCTs are usually more aggressive and have poorer prognosis than nonseminomatous TGCTs. Most nonseminomatous MGCT cases show early resistance to platinum-based therapies and seldom have been associated with the onset of one or more concomitant somatic malignancies, in particular myeloid neoplasms with recent findings supporting a common, shared genetic precursor with the primary MGCT. Genomic, transcriptomic and epigenetic features of testicular GCTs have been extensively studied, allowing for the understanding of GCT development and transformation of seminomatous and nonseminomatous histologies. However, MGCTs are still lacking proper multi-omics analysis and only few data are reported in the literature. Understanding of the mechanism involved in the development, in the progression and in their higher resistance to common therapies is still poorly understood. With this review, we aim to collect all molecular findings reported in this rare disease, resuming the similarities and disparities with the gonadal counterparts.<\/jats:p>","DOI":"10.3390\/cancers13205223","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T23:13:32Z","timestamp":1634598812000},"page":"5223","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-9098","authenticated-orcid":false,"given":"Milena","family":"Urbini","sequence":"first","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via P. Maroncelli 40, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-4869","authenticated-orcid":false,"given":"Giuseppe","family":"Schepisi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via P. Maroncelli 40, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bleve","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via P. Maroncelli 40, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Virga","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via P. Maroncelli 40, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9496-6719","authenticated-orcid":false,"given":"Caterina","family":"Gianni","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via P. Maroncelli 40, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4036-5568","authenticated-orcid":false,"given":"Giorgia","family":"Gurioli","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via P. Maroncelli 40, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ulivi","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via P. Maroncelli 40, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7520-2908","authenticated-orcid":false,"given":"Ugo","family":"De Giorgi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Via P. Maroncelli 40, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.canep.2013.04.003","article-title":"Network of German Cancer Registries (GEKID). In-cidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998\u20132008","volume":"37","author":"Rusner","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/annonc\/mdf003","article-title":"Extragonadal retroperitoneal germ cell tumor: Evidence of origin in the testis","volume":"13","author":"Scholz","year":"2002","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdm472","article-title":"Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): Results of the sCR2 international study","volume":"19","author":"Fizazi","year":"2007","journal-title":"Ann. Oncol."},{"key":"ref_4","unstructured":"Kang, J., Mashaal, H., and Anjum, F. (2021). Mediastinal Germ Cell Tumors. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/sajc.sajc_47_19","article-title":"Primary malignant mediastinal germ cell tumors: A single institutional experience","volume":"09","author":"Mishra","year":"2020","journal-title":"S. Asian J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.20.03296","article-title":"Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results from the IGCCCG Update Consortium","volume":"39","author":"Gillessen","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41568-019-0178-9","article-title":"Human germ cell tumours from a developmental perspective","volume":"19","author":"Oosterhuis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12094-016-1566-1","article-title":"SEOM clinical guidelines for the management of germ cell testicular cancer (2016)","volume":"18","author":"Aparicio","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1200\/JCO.1998.16.2.725","article-title":"Primary mediastinal nonseminomatous germ cell tumors: Results of modern therapy including cisplatin-based chemotherapy","volume":"16","author":"Fizazi","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2605.1987.tb00161.x","article-title":"Carcinoma-in-situ of the testis: Possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma","volume":"10","author":"Berthelsen","year":"1987","journal-title":"Int. J. Androl."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rijlaarsdam, M., Tax, D.M.J., Gillis, A.J.M., Dorssers, L.C.J., Koestler, D..C., de Ridder, J., and Looijenga, L.H.J. (2015). Genome Wide DNA Methylation Profiles Provide Clues to the Origin and Pathogenesis of Germ Cell Tumors. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122146"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<809::AID-IJC20>3.0.CO;2-0","article-title":"A molecular model for the development of germ cell cancer","volume":"83","author":"Looijenga","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41416-019-0381-1","article-title":"Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development","volume":"120","author":"Dorssers","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/annonc\/mdu585","article-title":"Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: A population-based study","volume":"26","author":"Kier","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/path.1872","article-title":"Germ cell lineage differentiation in non-seminomatous germ cell tumours","volume":"208","author":"Honecker","year":"2005","journal-title":"J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","article-title":"Integrated Molecular Characterization of Testicular Germ Cell Tumors","volume":"23","author":"Shen","year":"2018","journal-title":"Cell Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1200\/PO.20.00166","article-title":"Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs","volume":"4","author":"Cheng","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(94)90235-6","article-title":"Origin of adult male mediastinal germ-cell tumours","volume":"343","author":"Chaganti","year":"1994","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bjc.1995.85","article-title":"Cancer incidence in men with Klinefelter syndrome","volume":"71","author":"Hasle","year":"1995","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/andr.294","article-title":"Familial testicular germ cell tumors (FTGCT)\u2014Overview of a multidisciplinary etiologic study","volume":"3","author":"Greene","year":"2014","journal-title":"Andrology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.beem.2007.05.001","article-title":"Tumor risk in disorders of sex development (DSD)","volume":"21","author":"Looijenga","year":"2007","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ng.3896","article-title":"Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor","volume":"49","author":"Litchfield","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ng.3879","article-title":"Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor","volume":"49","author":"Wang","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamaoncol.2018.6477","article-title":"Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors","volume":"5","author":"Aldubayan","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/humrep\/16.5.972","article-title":"Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects","volume":"16","author":"Skakkebaek","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_26","first-page":"2285","article-title":"Cytogenetic analysis of 124 prospectively ascer-tained malegerm cell tumors","volume":"52","author":"Rodriguez","year":"1992","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<134::AID-GCC9>3.0.CO;2-Y","article-title":"Chromo-some abnormalities of eighty-one pediatric germ cell tumors: Sex-, age-, site-, and histopathology-related differences\u2014A children\u2019s cancer group study","volume":"25","author":"Bussey","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/PAS.0000000000001164","article-title":"A Clinicopathologic and Molecular Analysis of 34 Mediastinal Germ Cell Tumors Suggesting Different Modes of Teratoma Development","volume":"42","author":"Kao","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_29","first-page":"7268","article-title":"Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors","volume":"61","author":"Schneider","year":"2001","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gcc.10053","article-title":"Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents","volume":"34","author":"Schneider","year":"2002","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1073\/pnas.2235735100","article-title":"Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors","volume":"100","author":"Sperger","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.onc.1206302","article-title":"Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2\u2013p12.1","volume":"22","author":"Rodriguez","year":"2003","journal-title":"Oncogene"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature20596","article-title":"Genomic evolution and chemoresistance in germ-cell tumours","volume":"540","author":"Zack","year":"2016","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/s41467-020-15768-x","article-title":"Genomic landscape of platinum resistant and sensitive testicular cancers","volume":"11","author":"Loveday","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1038\/ncomms6973","article-title":"Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours","volume":"6","author":"Litchfield","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1593\/neo.05514","article-title":"Activating Mutations and\/or Expression Levels of Tyrosine Kinase Receptors GRB7, RAS, and BRAF in Testicular Germ Cell Tumors","volume":"7","author":"McIntyre","year":"2005","journal-title":"Neoplasia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1200\/JCO.2016.68.7798","article-title":"Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors","volume":"34","author":"Bagrodia","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1158\/1078-0432.CCR-13-2868","article-title":"Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors","volume":"20","author":"Feldman","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/01.LAB.0000032410.46986.7B","article-title":"Primary mediastinal seminomas: Evidence of single and multiple KIT mutations","volume":"82","author":"Przygodzki","year":"2002","journal-title":"Lab. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1634\/theoncologist.2018-0430","article-title":"Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart","volume":"24","author":"Necchi","year":"2018","journal-title":"Oncologist"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 world health organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.seminoncol.2019.04.001","article-title":"Primary mediastinal germ cell tumors","volume":"46","author":"Rosti","year":"2019","journal-title":"Semin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/annonc\/mdx259","article-title":"Salvage high-dose chemotherapy in female patients with relapsed\/refractory germ-cell tumors: A retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"28","author":"Richard","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.semdp.2006.02.009","article-title":"Mediastinal germ cell tumors","volume":"22","year":"2005","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s003300000725","article-title":"Mediastinal germ cell tumors: A radiologic\u2013pathologic review","volume":"11","author":"Drevelegas","year":"2001","journal-title":"Eur. Radiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.20.03292","article-title":"International germ cell cancer classification update consortium. survival and new prognosticators in metastatic seminoma: Results from the IGCCCG-update consortium","volume":"39","author":"Beyer","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejca.2005.08.043","article-title":"Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis","volume":"42","author":"Steyerberg","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref_48","first-page":"284","article-title":"Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features","volume":"29","author":"Rosti","year":"2011","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa067749","article-title":"High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors","volume":"357","author":"Einhorn","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.bmt.1705465","article-title":"A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization","volume":"38","author":"Kopf","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Prognostic Factors Study Group, Lorch, A., Beyer, J., Bascoul-Mollevi, C., Kramar, A., Einhorn, L.H., Necchi, A., Massard, C., De Giorgi, U., and Fl\u00e9chon, A. (2010). Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J. Clin. Oncol., 28, 4906\u20134911.","DOI":"10.1200\/JCO.2009.26.8128"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.bjc.6600999","article-title":"First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: A prospective trial","volume":"89","author":"Bokemeyer","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1200\/JCO.2001.19.3.682","article-title":"Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum","volume":"19","author":"Vuky","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2001.19.6.1641","article-title":"Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis","volume":"19","author":"Hartmann","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.hoc.2011.03.007","article-title":"A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors","volume":"25","author":"Voss","year":"2011","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.2010.32.6678","article-title":"Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: Evidence from a large international database","volume":"29","author":"Lorch","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdi017","article-title":"Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: The EBMT experience","volume":"16","author":"Demirer","year":"2005","journal-title":"Ann. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.eururo.2006.05.011","article-title":"Phase II Study of Oxaliplatin and Gemcitabine Salvage Chemotherapy in Patients with Cisplatin-Refractory Nonseminomatous Germ Cell Tumor","volume":"50","author":"Rosti","year":"2006","journal-title":"Eur. Urol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.2016.69.5395","article-title":"High-dose chemotherapy and autologous peripheral-blood stem-cell transplantation for relapsed metastatic germ cell tumors: The indiana university experience","volume":"35","author":"Adra","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fonc.2020.01325","article-title":"Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy","volume":"10","author":"Cursano","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/bjc.2017.460","article-title":"Systemic immune-inflammation index in germ-cell tumours","volume":"118","author":"Chovanec","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bjc.2017.467","article-title":"Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy","volume":"118","author":"Fankhauser","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5152\/tud.2016.38924","article-title":"Predictive value of preoperative neutrophil-to-lymphocyte ratio on the prognosis of germ cell testicular tumors","volume":"43","author":"Bolat","year":"2017","journal-title":"Turk. J. Urol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4149\/BLL_2017_098","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of preoperative tumor staging in testicular germ cell tumors","volume":"118","author":"Jankovich","year":"2017","journal-title":"Bratisl. Med. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/1097-0142(20000601)88:11<2629::AID-CNCR27>3.0.CO;2-F","article-title":"The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors","volume":"88","author":"Hartmann","year":"2000","journal-title":"Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7326\/0003-4819-102-5-603","article-title":"Hematologic malignancies associated with primary mediastinal germ cell tumors","volume":"102","author":"Nichols","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-017-3037-3","article-title":"Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia","volume":"96","author":"Mukherjee","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1002\/1097-0142(19930615)71:12<3873::AID-CNCR2820711214>3.0.CO;2-1","article-title":"Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors","volume":"71","author":"Orazi","year":"1993","journal-title":"Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1172\/JCI139682","article-title":"Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor","volume":"130","author":"Taylor","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/gcc.2870010113","article-title":"Leukemic differentiation of a mediastinal germ cell tumor","volume":"1","author":"Chaganti","year":"1989","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jnci\/82.3.221","article-title":"Cytogenetic and Immunohistochemical Evidence for the Germ Cell Origin of a Subset of Acute Leukemias Associated With Mediastinal Germ Cell Tumors","volume":"82","author":"Ladanyi","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.1994.tb04997.x","article-title":"Acute myeloid leukaemia with +i(12p) shortly after treatment of mediastinal germ cell tumour","volume":"88","author":"Vlasveld","year":"1994","journal-title":"Br. J. Haematol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/MPH.0000000000001233","article-title":"Hematologic Malignancies Associated With Mediastinal Germ Cell Tumors: 10 Years\u2019 Experience at Thailand\u2019s National Pediatric Tertiary Referral Center","volume":"40","author":"Sowithayasakul","year":"2018","journal-title":"J. Pediatr. Hematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"a000687","DOI":"10.1101\/mcs.a000687","article-title":"A common founding clone withTP53andPTENmutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia","volume":"2","author":"Lu","year":"2016","journal-title":"Mol. Case Stud."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-016-0258-1","article-title":"Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent","volume":"9","author":"Leonard","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cancergen.2014.03.009","article-title":"Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor","volume":"207","author":"Oshrine","year":"2014","journal-title":"Cancer Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6497-0","article-title":"TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia","volume":"20","author":"Akizuki","year":"2020","journal-title":"BMC Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/1093526620951327","article-title":"Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics","volume":"23","author":"Amra","year":"2020","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1172\/JCI143884","article-title":"Mediastinal germ cell tumors: Many questions and perhaps an answer","volume":"130","author":"Oosterhuis","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1200\/JCO.1987.5.8.1290","article-title":"Klinefelter\u2019s syndrome associated with mediastinal germ cell neoplasms","volume":"5","author":"Nichols","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/PAS.0000000000001615","article-title":"Vasculogenic Mesenchymal Tumor: A Clinicopathologic and Molecular Study of 55 Cases of a Distinctive Neoplasm Originating From Mediastinal Yolk Sac Tumor and an Occasional Precursor to Angiosarcoma","volume":"45","author":"Levy","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/13543784.2016.1195808","article-title":"Investigational targeted therapies for the treatment of testicular germ cell tumors","volume":"25","author":"Oing","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10637-019-00805-4","article-title":"Phase II study of avelumab in multiple relapsed\/refractory germ cell cancer","volume":"37","author":"Mego","year":"2019","journal-title":"Investig. New Drugs"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/annonc\/mdx680","article-title":"Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: A hoosier cancer research network study GU14-206","volume":"29","author":"Adra","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1158\/2326-6066.CIR-16-0087","article-title":"Clinical response of a patient to anti-PD-1 immunotherapy and the immune landscape of testicular germ cell tumors","volume":"4","author":"Shah","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","article-title":"Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate","volume":"14","author":"Scher","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1634\/theoncologist.2018-0784","article-title":"Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial","volume":"24","author":"Nicolazzo","year":"2019","journal-title":"Oncologist"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1158\/1078-0432.CCR-13-2819","article-title":"Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors","volume":"20","author":"Nastaly","year":"2014","journal-title":"Clin. Cancer Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5223\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:17:20Z","timestamp":1760167040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":88,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["cancers13205223"],"URL":"https:\/\/doi.org\/10.3390\/cancers13205223","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]}}}